PRECIOUS METAL: Gold traded positive on Tuesday, supported by Sino-U.S. trade tensions and global stimulus although hopeful early-stage data for a potential COVID-19 vaccine encouraged some risk appetite, keeping prices below the 48,000 marks. Even though the newsflash on a possible coronavirus vaccine igniting a excitement in the equity markets, yellow metal will persist very well bid due to the unreasonably massive Federal Reserve balance sheet. On Monday, US stocks and oil surged after drug maker Moderna said its COVID-19 trial vaccine showed promising results in an early-stage trial. Indicating some return to normalcy, epicentres of the pandemic, including New York, Italy and Spain, are slowly lifting restrictions that have kept millions inside. The metal has surged more than 22% this year so far as central banks rolled out a wave of interest rate cuts and other stimulus to limit the economic damage from the pandemic.